Potomac Capital Management, Inc. Enzo Biochem Inc Transaction History
Potomac Capital Management, Inc.
- $56.8 Million
- Q4 2023
A detailed history of Potomac Capital Management, Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Potomac Capital Management, Inc. holds 1,481,742 shares of ENZ stock, worth $814,958. This represents 3.63% of its overall portfolio holdings.
Number of Shares
1,481,742
Previous 1,455,000
1.84%
Holding current value
$814,958
Previous $2.04 Million
1.13%
% of portfolio
3.63%
Previous 2.75%
Shares
8 transactions
Others Institutions Holding ENZ
# of Institutions
14Shares Held
4.29MCall Options Held
0Put Options Held
0-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
-
Black Rock Inc. New York, NY955KShares$525,2620.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA150KShares$82,5000.0% of portfolio
-
Squarepoint Ops LLC New York, NY141KShares$77,3500.0% of portfolio
-
Lepercq Multi Asset Fund Hamilton, D0123KShares$67,6500.06% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...